C5 and premenstrual tension: Additional studies targeting a wider range of patients other than the PMS are thereby needed to properly validate the aHUS diagnostic cutoff score of 5 using the TMA/aHUS score, and further assess its utility to predict treatment response with C5 inhibitors.